A Game Changer in Drug Discovery

Our AI-based platform and expertise saves time and effort in the early phases of drug discovery

Search

  • 1 Second Billion Scale Search

  • 3D Shape | Electrostatics | Activity Screening

  • Saves Years of Time in Virtual Screening

  • Enamine, ZINC, 5+ DBs Coming Soon

Modeller

  • Ultra-Fast ADMET Prediction

  • Train Custom QSAR in 2 Minutes

  • The Simplest GUI on the Market

Explorer

  • 11+ Public Databases

  • 3D Shape | Electrostatics | Activity

  • FDA Approved Drugs | Patented Molecules

  • Natural Products | Nutrition | Fragrances

Electrostatics

  • 95-98% Correlation with DFT

  • Validated on OOD scaffold-split (molecules less than 0.3 Morgan Tanimoto to training set)

  • 3s for molecules taking 3hours with DFT

Our customers and partners

Arise Health logoArise Health logoArise Health logoArise Health logo
Arise Health logoArise Health logoArise Health logoArise Health logo

Subscribe to our updates

AI is revolutionising drug discovery.
We will make you part of this revolution.

Deep MedChem is a spin-off from The MAMA AI and i&i Prague (startup investor and incubator connected with IOCB, a top-class medicinal chemistry institution in Europe), leading entities in the space of artificial intelligence and medicinal chemistry.

The collaboration led to the development of CHEESE platform---a family of AI products for drug discovery that accelerate the early phases of drug discovery.

Try for free
Collaboration with Deep MedChem has significantly streamlined the implementation of AI/ML technologies for processing chemoinformatics data in our drug discovery processes. Through a series of open consultations, the members of Deep MedChem quickly and effectively understood our needs. As a result of this collaboration, we now possess several proprietary models that provide us with significant competitive advantage over other solutions.
Jan Skácel
Research Group Lead, IOCB Prague
CHEESE Modeller has been a game-changer for our drug discovery projects.
The tool accurately predicted docking scores in our virtual screening saving us 200 days of computation time, while achieving unprecedented hit rate. Its simplicity and ease of use set it apart from competitors. Additionally, their customer support is outstanding, always providing prompt and effective assistance including updates in their product. Collaborating with Deep MedChem has boosted our research capabilities and competitive advantage.
Chief Scientific Officer
A San Francisco Bay Area Biotech Company

We Are The Solution For You

  • Deep MedChem’s AI expert services and platform for drug discovery, CHEESE, are the right toolkit to accelerate your early phase drug discovery workflows.
  • You are not left alone with the tools as we offer expert services to ensure you achieve the best results in the shortest time frame.

How do we do it?

Navigating the AI space on your own can be daunting---complexity of AI tools, lack of expertise, and uncertainty about the outcomes.
‍
We resolve initial uncertainty from AI tools by services of our experts with experience from collaborations with medicinal chemists:

  • check_circle

    Intuitive GUI of CHEESE platform simplifies the operation of AI in your research workflows.
    With our experts you learn how to utilise the power of AI tools optimally.

  • check_circle

    We have deep experience with data analysis and result interpretation.
    We make sure that results are clear, actionable, and aligned with your research goals. 

  • check_circle

    We assist you in optimising your datasets and provide guidance on data enrichment strategies.
    Our platform is designed to work effectively even with limited data, ensuring reliable predictions. 

  • check_circle

    Seamless integration into customer workflows is corner stone of our platform design.
    Either done by you or our experts, the integration is efficient and straightforward.

Services

Expert Services

Derived from our drug discovery AI platform, our expert team provides hands-on assistance.

Collaborative Approach

We work closely with you, tailoring our support to meet your specific goals and requirements.

Accessible AI Tools

Our AI tools bridge the gap between cutting-edge technology and practical application.

Our Team

We are passionate about making AI-tools that provide the most added value in the hands of medicinal chemists and drug developers in the early phases of drug discovery.

Jan Macek

Chief Executive Officer

Miroslav Lžičař

Chief Technical Officer

Jiří Růžička

Chief Business Officer

Hamza Gamouh

Senior AI Engineer

David Stíbal

Senior Biotech Venture Capital Expert
(Supervisory Board Member)

Jan Kleindienst

Senior AI Executive
(Supervisory Board Member)